Photo taken from John Byrd/LinkedIn
Oct 15, 2023, 15:13
John Byrd: So great to be together with these great friends who have a passion for developing new therapies and caring for patients with CLL.
John Byrd,
“Last weekend many of us were together at the International Workshop in CLL in Boston. Pictured here is Drs. Deborah Stephens, Jeff Sharman, Kanti Rai and myself. So great to be together with these great friends who have a passion for developing new therapies and caring for patients with CLL. Also so exciting to hear Dr. Molica’s presentation that CLL patients requiring therapy who went onto Bruton’s tyrosine kinase inhibitors (acalabrutinib and ibrutinib) have a survival similar to the age and sex match control population.”
Source: John Byrd/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14